Skip to main content

Beckman Coulter Cuts 84 Positions

NEW YORK (GenomeWeb News) – Beckman Coulter officials confirmed today that the firm has informed 84 employees at its sites in Fullerton and Brea, Calif., that their positions are being eliminated.

The Orange County Business Times reported yesterday that 52 of the job cuts are in Brea, while the remaining jobs are at the firm's Fullerton site. The firm said at the beginning of 2008 that it was moving its headquarters from Fullerton to nearby Brea, but at the time there were no layoffs associated with the move. However, it did cut 158 jobs from its Palo Alto, Calif., operations.

A Beckman Coulter spokesperson told GenomeWeb Daily News via e-mail today that the cuts are due to the consolidation of its facility in Orange County and due to "adjustments to our structure because of the Olympus acquisition."

Beckman Coulter recently completed its $780 million acquisition of Olympus' lab-based diagnostics business. The deal provided Beckman with an expanded clinical chemistry offering with particular strength in the larger hospital laboratories.

Filed under

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.